ArticleClinical pharmacology and therapeutics2026

Minor Contribution of UGT1A1 Inhibition to Atazanavir-Related Bilirubin Elevation Supported by Conservative PBPK Modeling and Clinical Data.

Jin Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.